4.7 Article

Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pediatrics

Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?

Daniel Jarovsky et al.

Summary: This article reviews the impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pediatric pneumococcal infections, carriage, serotype replacement, and antimicrobial resistance in Brazil since 2010. The use of PCV10 has led to declines in hospitalization rates of all-cause pneumonia and significant reductions in pneumococcal meningitis burden, fatality rates, and intensive care unit admissions. However, the impact on otitis media and the emergence of penicillin non-susceptibility pneumococci have been less clear.

JORNAL DE PEDIATRIA (2023)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator- controlled, multicentre, US-based trial

Heather Platt et al.

Summary: This study evaluated an investigational 21-valent pneumococcal conjugate vaccine (V116) specifically targeting serotypes associated with residual disease burden in adults. The results showed that V116 had a similar safety and immunogenicity profile compared to PPSV23, and was superior to PPSV23 for nine unique serotypes. These findings support the use of V116 for prevention of pneumococcal disease in adults.

LANCET INFECTIOUS DISEASES (2023)

Article Immunology

Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study

Dana Danino et al.

Summary: During the COVID-19 pandemic in Israel, reductions in pneumococcal and pneumococcus-associated diseases were strongly associated with the disappearance of specific respiratory viruses, rather than reduced pneumococcal carriage and density.

CLINICAL INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France

Alexis Rybak et al.

Summary: This study examined the impact of nonpharmaceutical interventions implemented during the COVID-19 pandemic on the incidence of invasive pneumococcal disease (IPD) in France. The results showed that the decrease in IPD incidence was associated with decreased viral infection cases, rather than changes in pneumococcal carriage rate.

JAMA NETWORK OPEN (2022)

Article Immunology

Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries

Lucia H. de Oliveira et al.

Summary: A multi-country evaluation in Latin American and Caribbean countries showed that the introduction of pneumococcal conjugate vaccines led to a decline in pneumonia mortality among children aged 2-59 months in some countries. However, the impact varied across countries and age groups, suggesting the need for further research and monitoring of vaccine effectiveness.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019

Maria-Cristina C. Brandileone et al.

Summary: The study found that antimicrobial non-susceptible Streptococcus pneumoniae decreased in the three years after the introduction of PCV10 vaccine, but subsequently increased, especially in the period of 2017-2019, particularly among children under 5 years with meningitis. Multidrug resistance reached 25% during this period. Serotypes 19A, 6C, and 23A were most associated with antimicrobial non-susceptibility.

VACCINE (2021)

Editorial Material Infectious Diseases

World Meningitis Day and the World Health Organization's roadmap to defeat bacterial meningitis in the COVID-19 pandemic era

Tatiana Castro Abreu Pinto et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogota, Colombia

David Felipe Severiche-Bueno et al.

Summary: This study investigated the epidemiology of IPD and the impact of PCV-10 in Bogota, Colombia over a 10-year period. The introduction of PCV-10 led to a decrease in IPD incidence, especially in children, with no effect on patients aged 50 and over.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Genetics & Heredity

Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil

Samanta C. G. Almeida et al.

Summary: After the introduction of PCV10 in Brazil in 2010, non-vaccine serotypes 3 and 19A were most common in the <5 years age group, while serotypes 12F, 8, and 9 N predominated in the >=5 years age group. The study identified various global and Brazilian pneumococcal sequence clusters, with changes observed in antimicrobial resistance profiles following PCV10 introduction.

MICROBIAL GENOMICS (2021)

Review Microbiology

The Impact and Burden of Neurological Sequelae Following Bacterial Meningitis: A Narrative Review

Nicoline Schiess et al.

Summary: Neurological sequelae following meningitis can have devastating effects on patients, families, and communities, with high mortality rates and survivors often experiencing various neurological disabilities. Limited research exists on the long-term consequences, age-related outcomes, and socioeconomic impact of this condition, especially in low- and middle-income countries. Addressing these gaps is crucial for understanding and mitigating the burden of bacterial meningitis-related disabilities.

MICROORGANISMS (2021)

Article Microbiology

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

Maria Garcia Quesada et al.

Summary: Introduction of PCV has reduced pneumococcal meningitis incidence, with remaining cases showing different serotype distribution in countries using PCV10/13 for at least 5-7 years. Higher-valency PCVs may target over half of remaining cases, but further data is needed for generalizability in the African meningitis belt.

MICROORGANISMS (2021)

Article Public, Environmental & Occupational Health

The burden of disease among Brazilian older adults and the challenge for health policies: results of the Global Burden of Disease Study 2017

Valeria Maria de Azeredo Passos et al.

POPULATION HEALTH METRICS (2020)

Review Infectious Diseases

Making sense of differences in pneumococcal serotype replacement

Joseph A. Lewnard et al.

LANCET INFECTIOUS DISEASES (2019)

Article Public, Environmental & Occupational Health

Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006-2016

C. Houseman et al.

EPIDEMIOLOGY AND INFECTION (2019)

Review Infectious Diseases

Epidemiology of community-acquired bacterial meningitis

Matthijs C. Brouwer et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2018)

Review Multidisciplinary Sciences

Global etiology of bacterial meningitis: A systematic review and meta-analysis

Anouk M. Oordt-Speets et al.

PLOS ONE (2018)

Review Biotechnology & Applied Microbiology

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis

Ana Lucia Andrade et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Article Critical Care Medicine

Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study

Carla Magda Allan S. Domingues et al.

LANCET RESPIRATORY MEDICINE (2014)

Review Neurosciences

Evolution of bacterial meningitis diagnosis in Sao Paulo State-Brazil and future challenges

Maristela Marques Salgado et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2013)

Review Medicine, General & Internal

Serotype replacement in disease after pneumococcal vaccination

Daniel M. Weinberger et al.

LANCET (2011)